Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer

StatusWithdrawn
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Trial status: Terminated to Withdrawnv8
  3. Trial status: Active, Not Recruiting to Terminated Sponsor's reason: PI left institutionv7 Show 4 more changesShow less
    • Lead sponsor: Massey Cancer Center to Virginia Commonwealth University
    • Enrollment target: 0
    • Primary and study completion dates: Dec 2000
    • Collaborators expanded, about 4 words
  4. Interventions: radiation therapy (Procedure) to radiation therapy (Radiation)v6
  5. 2 versions Re-verified since Oct 25, 2007, no change to tracked fieldsv4-v5
Show 2 earlier versionsHide 2 earlier versions
  1. Interventions: Prophylactic cranial irradiation in lung cancer patients (Procedure) to radiation therapy (Procedure)
    • Eligibility criteria shortened, about 2 words
    • Study description shortened, about 1 word
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which regimen of radiation therapy may be more effective in preventing brain metastases. PURPOSE: Randomized phase III trial to study the effectiveness of radiation therapy in preventing brain metastases in patients who have small cell lung cancer that has been diagnosed within the past year.
Trial Details
NCT Number NCT00006344
Lead Sponsor Virginia Commonwealth University
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov